LIPOVÝ, Břetislav and Michaela CVANOVÁ. The role of antithrombin in patients with toxic epidermal necrolysis. Burns. OXFORD: ELSEVIER SCI LTD, 2017, vol. 43, No 5, p. 1135-1137. ISSN 0305-4179. Available from: https://dx.doi.org/10.1016/j.burns.2017.01.031.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The role of antithrombin in patients with toxic epidermal necrolysis
Authors LIPOVÝ, Břetislav (203 Czech Republic, guarantor, belonging to the institution) and Michaela CVANOVÁ (203 Czech Republic, belonging to the institution).
Edition Burns, OXFORD, ELSEVIER SCI LTD, 2017, 0305-4179.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30218 General and internal medicine
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.134
RIV identification code RIV/00216224:14110/17:00098654
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.burns.2017.01.031
UT WoS 000403985900032
Keywords in English antithrombin
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 18:51.
Abstract
Toxic epidermal necrolysis (TEN) is a rare systemic disease, which is predominantly manifested in the skin and mucous membranes. Its indicated incidence in the population is 0.5–1.5 cases per million inhabitants a year. It is the most severe syndrome from the SCARs group (Severe Cutaneous Adverse Reactions) with mortality around 30–50%.
PrintDisplayed: 21/8/2024 05:31